title: Role of endogenous hypergastrinemia in regenerating endocrine pancreas after partial pancreatectomy.
abstract: We studied the possible role of endogenous gastrin in the regenerating pancreas. Male Wistar rats underwent sham operation or 90% partial pancreatectomy (Px). Lansoprazole (30 mg/kg body wt), a proton pump inhibitor (PPI), was given p.o. for 3 weeks after surgery. Plasma glucose levels were higher in Px rats than in shams. Lansoprazole lowered plasma glucose levels in the Px rats. In addition, integrated insulin secretion during an oral glucose tolerance test (2 g/kg body wt) was significantly (p < 0.01) higher in lansoprazole-treated Px rats than in control Px rats, while lansoprazole did not affect insulin secretion in shams. Fasting serum gastrin levels were higher (p < 0.01) in lansoprazole-treated animals than in controls both in sham rats and in Px rats. Furthermore, lansoprazole increased the pancreas weight per body weight and elevated the insulin content of the pancreas in Px rats. These results suggest that endogenous hypergastrinemia has a trophic effect on endocrine pancreas during regenerating processes and that administration of PPI may be clinically beneficial to the remnant pancreas after pancreatectomy if the whole stomach is preserved.
authors.affiliation: First Department of Surgery, Shimane Medical University, Izumo, Japan.
authors.forename: G
authors.initials: G
authors.lastname: Xu
authors.forename: S
authors.initials: S
authors.lastname: Sumi
authors.forename: M
authors.initials: M
authors.lastname: Koike
authors.forename: K
authors.initials: K
authors.lastname: Tanigawa
authors.forename: Y
authors.initials: Y
authors.lastname: Nio
authors.forename: K
authors.initials: K
authors.lastname: Tamura
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D005755:Gastrins / Q000187:drug effects / Q000502:physiology*; D007328:Insulin / Q000378:metabolism; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects; D010179:Pancreas / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D010180:Pancreatectomy; D011506:Proteins / Q000378:metabolism; D054328:Proton Pump Inhibitors; D051381:Rats; D017208:Rats, Wistar; D012038:Regeneration / Q000502:physiology*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001786:Blood Glucose; D005755:Gastrins; D007328:Insulin; D011506:Proteins; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole